THIRUVANANTHAPURAM: In a major breakthrough, doctors at Sree Chitra Tirunal Institute for Medical Sciences and Technology ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
“Consuming foods high in sugar, such as pastries, can significantly impact your cholesterol profile, primarily by altering ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
The Family Heart Foundation, a leading research and advocacy organization, published new research in the American Journal of Preventive Cardiology revealing significant gaps in cholesterol management ...
SCTIMST performs its first LDL apheresis for Familial Hypercholesterolemia, dramatically lowering cholesterol in a 34-year-old patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results